BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang J, Islam R, Islam W, Yin H, Subr V, Etrych T, Ulbrich K, Maeda H. Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents. Pharmaceutics 2019;11:E343. [PMID: 31315251 DOI: 10.3390/pharmaceutics11070343] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohammadzadeh V, Rahiman N, Hosseinikhah SM, Barani M, Rahdar A, Jaafari MR, Sargazi S, Zirak MR, Pandey S, Bhattacharjee R, Gupta AK, Thakur VK, Sibuh BZ, Gupta PK. Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update. Journal of Drug Delivery Science and Technology 2022;73:103459. [DOI: 10.1016/j.jddst.2022.103459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sharifi M, Cho WC, Ansariesfahani A, Tarharoudi R, Malekisarvar H, Sari S, Bloukh SH, Edis Z, Amin M, Gleghorn JP, Hagen TLMT, Falahati M. An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment. Cancers (Basel) 2022;14:2868. [PMID: 35740534 DOI: 10.3390/cancers14122868] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Azevedo S, Costa-almeida R, Santos SG, Magalhães FD, Pinto AM. Advances in carbon nanomaterials for immunotherapy. Applied Materials Today 2022;27:101397. [DOI: 10.1016/j.apmt.2022.101397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Guo C, Zhang C, Xia Z, Song B, Hu W, Cui Y, Xue Y, Xia M, Xu D, Zhang S, Fang J. Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation. J Control Release 2021;341:566-77. [PMID: 34864115 DOI: 10.1016/j.jconrel.2021.11.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tracey SR, Smyth P, Barelle CJ, Scott CJ. Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface. Biochem Soc Trans 2021;49:2253-69. [PMID: 34709394 DOI: 10.1042/BST20210343] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Sun Y, An C, Wu L, Zeng W, Wang J, Wang Y, He J, Gao G, Ye D. Degradable FeCuS-Lipid Nanoparticles Confer Ultrasound-Activated CO Release and O2-Independent Radical Production for Synergistic Therapy. ACS Nano 2021;15:16298-313. [PMID: 34590840 DOI: 10.1021/acsnano.1c05485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Appiah E, Nakamura H, Pola R, Grossmanová E, Lidický O, Kuniyasu A, Etrych T, Haratake M. Acid-responsive HPMA copolymer-bradykinin conjugate enhances tumor-targeted delivery of nanomedicine. J Control Release 2021;337:546-56. [PMID: 34375687 DOI: 10.1016/j.jconrel.2021.08.009] [Reference Citation Analysis]
8 Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J Pers Med 2021;11:571. [PMID: 34207137 DOI: 10.3390/jpm11060571] [Cited by in F6Publishing: 36] [Reference Citation Analysis]
9 Islam W, Kimura S, Islam R, Harada A, Ono K, Fang J, Niidome T, Sawa T, Maeda H. EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect. J Pers Med 2021;11:487. [PMID: 34071552 DOI: 10.3390/jpm11060487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Islam R, Gao S, Islam W, Šubr V, Zhou JR, Yokomizo K, Etrych T, Maeda H, Fang J. Unraveling the role of Intralipid in suppressing off-target delivery and augmenting the therapeutic effects of anticancer nanomedicines. Acta Biomater 2021;126:372-83. [PMID: 33774199 DOI: 10.1016/j.actbio.2021.03.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Song C, Ouyang Z, Guo H, Qu J, Gao Y, Xia J, Shen M, Shi X. Core-Shell Tecto Dendrimers Enable Enhanced Tumor MR Imaging through an Amplified EPR Effect. Biomacromolecules 2021;22:2181-8. [PMID: 33848141 DOI: 10.1021/acs.biomac.1c00262] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Chytil P, Kostka L, Etrych T. HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery. J Pers Med 2021;11:115. [PMID: 33578756 DOI: 10.3390/jpm11020115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Islam R, Maeda H, Fang J. Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors. Expert Opin Drug Deliv 2021;:1-14. [PMID: 33430661 DOI: 10.1080/17425247.2021.1874916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Song B, Zhang C, Hu W, Guo C, Xia Z, Hu W, Qin M, Jiang W, Lv J, Xu D, Zhang S, Fang J. Nano-designed carbon monoxide donor SMA/CORM2 exhibits protective effect against acetaminophen induced liver injury through macrophage reprograming and promoting liver regeneration. J Control Release 2021;331:350-63. [PMID: 33482271 DOI: 10.1016/j.jconrel.2021.01.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang E, Zuo Z, Yu W, Zhao H, Xia S, Huang Y, Lv F, Liu L, Li Y, Wang S. Photoactive conjugated polymer/graphdiyne nanocatalyst for CO 2 reduction to CO in living cells for hypoxia tumor treatment. Mater Chem Front 2021;5:5841-5. [DOI: 10.1039/d1qm00677k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
16 Islam W, Matsumoto Y, Fang J, Harada A, Niidome T, Ono K, Tsutsuki H, Sawa T, Imamura T, Sakurai K, Fukumitsu N, Yamamoto H, Maeda H. Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis. Biomaterials 2021;269:120631. [PMID: 33450582 DOI: 10.1016/j.biomaterials.2020.120631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhou J, Guo B, Zhu W, Sui X, Ma X, Qian J, Cao L, Han C. Novel biomimetic nanostructured lipid carriers for cancer therapy: preparation, characterization, and in vitro/in vivo evaluation. Pharm Dev Technol 2021;26:81-91. [PMID: 33070668 DOI: 10.1080/10837450.2020.1835957] [Reference Citation Analysis]
18 Carissimi G, Montalbán MG, Víllora G, Barth A. Direct Quantification of Drug Loading Content in Polymeric Nanoparticles by Infrared Spectroscopy. Pharmaceutics 2020;12:E912. [PMID: 32977658 DOI: 10.3390/pharmaceutics12100912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lu B, Zhou G, Xiao F, He Q, Zhang J. Stimuli-responsive poly(ionic liquid) nanoparticles for controlled drug delivery. J Mater Chem B 2020;8:7994-8001. [PMID: 32761012 DOI: 10.1039/d0tb01352h] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
20 Kopeček J, Yang J. Polymer nanomedicines. Adv Drug Deliv Rev 2020;156:40-64. [PMID: 32735811 DOI: 10.1016/j.addr.2020.07.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
21 Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, Alcudia A. Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials (Basel) 2020;10:E1403. [PMID: 32707641 DOI: 10.3390/nano10071403] [Cited by in Crossref: 43] [Cited by in F6Publishing: 115] [Article Influence: 21.5] [Reference Citation Analysis]
22 Fang J, Islam W, Maeda H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv Drug Deliv Rev 2020;157:142-60. [PMID: 32553783 DOI: 10.1016/j.addr.2020.06.005] [Cited by in Crossref: 151] [Cited by in F6Publishing: 164] [Article Influence: 75.5] [Reference Citation Analysis]
23 Huang X, Wu W, Yang W, Qing X, Shao Z. Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma. Colloids Surf B Biointerfaces 2020;190:110891. [PMID: 32114271 DOI: 10.1016/j.colsurfb.2020.110891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
24 Zhang Z, Yu M, An T, Yang J, Zou M, Zhai Y, Sun W, Cheng G. Tumor Microenvironment Stimuli-Responsive Polymeric Prodrug Micelles for Improved Cancer Therapy. Pharm Res 2020;37. [DOI: 10.1007/s11095-019-2709-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]